EUVIMEDEUVIMED entdecken
Crossref

JAK1 /2 Inhibitors Alleviate the Damage of Intercellular Adhesion by Reducing Endoplasmic Reticulum Stress‐Induced Apoptosis in Pemphigus Vulgaris

Xi Chen, Mei-Nian Xu, Zheng-Quan Wu, Rong Huang, Hong-Yan Lu, Xiaoming Peng, Kang Zeng iD, Chang-Xing Li

Experimental Dermatology · 2025

DOI: 10.1111/exd.70121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Dermatology, 2025. Verfasst von Xi Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Nanfang Hospital, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Apoptosis, Endoplasmic Reticulum Stress, Janus Kinase 1, Janus Kinase 2. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: The National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pemphigus vulgaris (PV), a severe autoimmune disease with high morbidity and mortality, necessitates innovative therapies to improve outcomes while minimising the adverse effects of conventional immunosuppressants. Immunohistochemical analysis revealed elevated phosphorylated Janus kinase (p‐JAK)1 and p‐JAK2 expression in PV lesions, complemented by transcriptome data showing JAK/STAT pathway dysregulation. Using a PV acantholysis model, we demonstrated that Ruxolitinib, a JAK1/2 inhibitor, significantly reduced keratinocyte apoptosis, enhanced cell adhesion, and alleviated endoplasmic reticulum (ER) stress. Additionally, Ruxolitinib mitigated tunicamycin‐induced ER stress and apoptosis in HaCaT cells. These findings establish a crucial role for JAK1/2 in PV pathogenesis, demonstrating that their inhibition alleviates ER stress, reduces apoptosis, and improves cell adhesion. Our results provide a theoretical foundation for the clinical application of JAK inhibitors in PV treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApoptosisEndoplasmic Reticulum StressJanus Kinase 1Janus Kinase 2PemphigusPyrazolesHumansCell AdhesionCell LineKeratinocytesNitrilesPhosphorylationProtein Kinase InhibitorsPyrimidinesSignal Transduction

Stichwörter der Autor:innen

JAK inhibitorsendoplasmic reticulum stresskeratinocyte adhesionkeratinocyte apoptosispemphigus vulgaris

Substanzen

JAK1 protein, humanJAK2 protein, humanJanus Kinase 1Janus Kinase 2NitrilesProtein Kinase InhibitorsPyrazolesPyrimidinesruxolitinib

Autor:innen und Institutionen

  • Department of Dermatology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Department of Dermatology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
  • Department of Dermatology, The Tenth Affiliated Hospital, Southern Medical University (Dongguan People's Hospital), Dongguan, China.

ORCID-Profile: Kang Zeng

Förderung

  • The National Natural Science Foundation of China

Zitieren

APA

Chen, X., Xu, M. N., Wu, Z. Q., Huang, R., Lu, H. Y., Peng, X., Zeng, K., & Li, C. X. (2025). JAK1 /2 Inhibitors Alleviate the Damage of Intercellular Adhesion by Reducing Endoplasmic Reticulum Stress‐Induced Apoptosis in Pemphigus Vulgaris. Experimental Dermatology. https://doi.org/10.1111/exd.70121

Vancouver

Chen X, Xu MN, Wu ZQ, Huang R, Lu HY, Peng X, et al. JAK1 /2 Inhibitors Alleviate the Damage of Intercellular Adhesion by Reducing Endoplasmic Reticulum Stress‐Induced Apoptosis in Pemphigus Vulgaris. Experimental Dermatology. 2025. doi:10.1111/exd.70121

BibTeX
@article{Chen2025,
  author = {Chen, Xi and Xu, Mei-Nian and Wu, Zheng-Quan and Huang, Rong and Lu, Hong-Yan and Peng, Xiaoming and Zeng, Kang and Li, Chang-Xing},
  title = {JAK1 /2 Inhibitors Alleviate the Damage of Intercellular Adhesion by Reducing Endoplasmic Reticulum Stress‐Induced Apoptosis in Pemphigus Vulgaris},
  journal = {Experimental Dermatology},
  year = {2025},
  doi = {10.1111/exd.70121}
}
Kostenlos starten →